Perbedaan UBC Medical Indonesia Tbk. dan Merck Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 2,9× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | MERK | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 1,7 T |
Volume | 3,48 jt | 37,6 rb |
Lot | 34,82 rb | 376 |
Perputaran | 522,79 jt | 144,47 jt |
Harga Rata-rata | 150,13 | 3.842,23 |
Nilai Transaksi | 522,79 jt | 144,47 jt |
Harga Ekuilibrium Indikatif | 148 | 3.840 |
Volume Ekuilibrium Indikatif | 350 | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →